Antibody-Induced Failure of Botulinum Toxin Type B Therapy in de novo Patients

Publisher： Karger

E-ISSN： 1421-9913|52|3|132-135

ISSN： 0014-3022

Source： European Neurology, Vol.52, Iss.3, 2004-11, pp. : 132-135

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Features of Antibody-Induced Complete Secondary Failure of Botulinum Toxin Therapy

By  

European Neurology, Vol. 48, Iss. 1, 2002-07 ,pp. : 26-29

Karger

Access to resources Recommend Favorite

Antibody-Induced Botulinum Toxin Therapy Failure: Can It Be Overcome by Increased Botulinum Toxin Doses?

By  

European Neurology, Vol. 47, Iss. 2, 2002-02 ,pp. : 118-121

Karger

Access to resources Recommend Favorite

Acute Neuromuscular Failure Related to Long-Term Botulinum Toxin Therapy

By  

European Neurology, Vol. 51, Iss. 3, 2004-05 ,pp. : 181-183

Karger

Access to resources Recommend Favorite

Botulinum Toxin Type B: Where Do We Stand?

By  

European Neurology, Vol. 46, Iss. 3, 2001-10 ,pp. : 113-114

Karger

Access to resources Recommend Favorite

Local Muscle Injection of Botulinum Toxin Type A Synergistically Improves the Beneficial Effects of Repetitive Transcranial Magnetic Stimulation and Intensive Occupational Therapy in Post-Stroke Patients with Spastic Upper Limb Hemiparesis

By  

European Neurology, Vol. 72, Iss. 5-6, 2014-10 ,pp. : 290-298

Karger

Access to resources Recommend Favorite